DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $703 | +0.7% | 61,003 | +1.2% | 0.01% | -21.4% |
| Q4 2022 | $698 | -99.8% | 60,257 | +130.0% | 0.01% | +100.0% |
| Q3 2022 | $333,000 | -30.8% | 26,200 | -62.6% | 0.01% | -46.2% |
| Q2 2022 | $481,000 | -9.4% | 70,063 | +27.1% | 0.01% | +8.3% |
| Q1 2022 | $531,000 | +14.2% | 55,131 | +40.9% | 0.01% | +50.0% |
| Q4 2021 | $465,000 | -4.9% | 39,115 | +68.4% | 0.01% | -11.1% |
| Q2 2021 | $489,000 | -57.3% | 23,230 | -68.5% | 0.01% | -60.9% |
| Q1 2021 | $1,145,000 | +406.6% | 73,758 | +585.1% | 0.02% | +283.3% |
| Q4 2020 | $226,000 | -16.9% | 10,766 | -20.1% | 0.01% | -50.0% |
| Q3 2020 | $272,000 | – | 13,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |